JPS5294411A - Disodium chromoglycate and pharmaceutical composition containing same - Google Patents

Disodium chromoglycate and pharmaceutical composition containing same

Info

Publication number
JPS5294411A
JPS5294411A JP793677A JP793677A JPS5294411A JP S5294411 A JPS5294411 A JP S5294411A JP 793677 A JP793677 A JP 793677A JP 793677 A JP793677 A JP 793677A JP S5294411 A JPS5294411 A JP S5294411A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition containing
containing same
disodium chromoglycate
chromoglycate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP793677A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6129929B2 (no
Inventor
Buraun Kennesu
Aasaa Suteiibunson Neiru
Furanshisu Kaaku Uiriamu
Buurusu Kuriibu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS5294411(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of JPS5294411A publication Critical patent/JPS5294411A/ja
Publication of JPS6129929B2 publication Critical patent/JPS6129929B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP793677A 1976-01-30 1977-01-28 Disodium chromoglycate and pharmaceutical composition containing same Granted JPS5294411A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (2)

Publication Number Publication Date
JPS5294411A true JPS5294411A (en) 1977-08-09
JPS6129929B2 JPS6129929B2 (no) 1986-07-10

Family

ID=26238506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP793677A Granted JPS5294411A (en) 1976-01-30 1977-01-28 Disodium chromoglycate and pharmaceutical composition containing same

Country Status (14)

Country Link
JP (1) JPS5294411A (no)
AU (1) AU512593B2 (no)
DE (1) DE2703119A1 (no)
DK (2) DK154766C (no)
ES (1) ES455478A1 (no)
FI (1) FI770215A (no)
FR (1) FR2339604A1 (no)
IE (1) IE44760B1 (no)
IL (1) IL51314A (no)
LU (1) LU76661A1 (no)
NL (1) NL185446C (no)
NO (2) NO151860C (no)
NZ (1) NZ183157A (no)
SE (2) SE442268B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56169624A (en) * 1980-04-30 1981-12-26 Fisons Ltd Biologically active mixture and salt of heterocyclic compound

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
CY1333A (en) * 1980-04-30 1986-10-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
JPS63138228U (no) * 1987-03-05 1988-09-12
JPS63138229U (no) * 1987-03-05 1988-09-12
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
EP0338670B1 (en) * 1988-03-22 1994-05-11 FISONS plc Pharmaceutical Compositions
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
JP3026841B2 (ja) * 1991-12-12 2000-03-27 グラクソ、グループ、リミテッド 医 薬
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
WO1993011747A1 (en) 1991-12-18 1993-06-24 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
ES2234266T3 (es) 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
NZ509489A (en) * 1998-08-04 2002-10-25 Jago Res A Medicinal aerosol formulations comprising cromoglycic acid and/or nedocromil
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (no) * 1956-03-21 1900-01-01
BE556587A (no) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56169624A (en) * 1980-04-30 1981-12-26 Fisons Ltd Biologically active mixture and salt of heterocyclic compound
JPH0149692B2 (no) * 1980-04-30 1989-10-25 Fisons Plc

Also Published As

Publication number Publication date
SE8107278L (sv) 1981-12-04
NO151860C (no) 1985-06-19
NO780183L (no) 1977-08-02
NL185446B (nl) 1989-11-16
SE442267B (sv) 1985-12-16
FR2339604B1 (no) 1980-12-05
NL7700911A (nl) 1977-08-02
ES455478A1 (es) 1978-02-01
AU512593B2 (en) 1980-10-16
DK154766C (da) 1989-05-22
IE44760B1 (en) 1982-03-24
FR2339604A1 (fr) 1977-08-26
DK357588A (da) 1988-06-29
AU2162677A (en) 1978-08-03
DK357588D0 (da) 1988-06-29
JPS6129929B2 (no) 1986-07-10
FI770215A (no) 1977-07-31
DK154766B (da) 1988-12-19
IL51314A0 (en) 1977-03-31
SE7700888L (sv) 1977-07-31
DE2703119C2 (no) 1990-10-25
DK38077A (da) 1977-07-31
NZ183157A (en) 1979-08-31
IL51314A (en) 1980-03-31
DE2703119A1 (de) 1977-08-04
DK156876C (da) 1990-03-12
SE442268B (sv) 1985-12-16
LU76661A1 (no) 1977-08-03
NO151860B (no) 1985-03-11
DK156876B (da) 1989-10-16
NO770286L (no) 1977-08-02
IE44760L (en) 1977-07-30
NL185446C (nl) 1990-04-17

Similar Documents

Publication Publication Date Title
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
JPS5294411A (en) Disodium chromoglycate and pharmaceutical composition containing same
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
PH23643A (en) Nasal pharmaceutical composition
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ185081A (en) Substituted phenylethylamines and pharmaceutical compositions containing them
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
ZA773935B (en) Peptide derivatives and pharmaceutical compositions containing same
JPS5362834A (en) Pharmaceutical composition and use thereof
IL52137A0 (en) Novel aryltrifluoroethylamines their preparation and pharmaceutical compositions containing them
IL51572A0 (en) New substituted purines and pharmaceutical compositions containing them
IL52409A0 (en) 5-m-tolyloxyuracil and pharmaceutical compositions containing it
PH12590A (en) 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
IL52528A0 (en) New peptide derivatives their manufacture and pharmaceutical compositions containing them
JPS5320433A (en) Pharmaceutical composition and application
IL53026A0 (en) New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
NZ183756A (en) Bis-penicillanoyloxy-alkanes and pharmaceutical compositions
IL52469A0 (en) New peptide derivatives their manufacture and pharmaceutical compositions containing them